| |
| |
|
| Insider
Information: |
Butitta Cynthia M |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
221,690 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$894 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
221,690 |
|
|
| Total
Value |
$894 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mabvax Therapeutics Holdings Inc |
MBVX |
COO and CFO |
2007-05-08 |
38,878 |
2004-09-16 |
0 |
Premium* |
|
|
Kite Pharma, Inc. |
KITE |
Chief Operating Officer |
2017-10-03 |
0 |
|
0 |
Premium* |
|
|
Olema Pharmaceuticals, Inc. |
OLMA |
Director |
2020-11-18 |
83,876 |
|
0 |
Premium* |
|
|
Century Therapeutics, Inc. |
IPSC |
Director |
2021-06-17 |
98,936 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IPSC |
Century Therapeutics, Inc... |
Director |
– • – |
2021-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
98,936 |
|
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
Director |
– • – |
2020-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
83,876 |
|
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
Director |
– • – |
2020-09-16 |
4 |
OE |
$4.41 |
$369,558 |
D/D |
83,876 |
83,876 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(93,667) |
0 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-09-25 |
4 |
S |
$179.66 |
$759,619 |
D/D |
(4,228) |
121,567 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
125,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-09-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
27,900 |
93,667 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-08-10 |
4 |
AS |
$120.52 |
$1,810,758 |
D/D |
(15,000) |
117,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-08-10 |
4 |
OE |
$1.35 |
$20,250 |
D/D |
15,000 |
132,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-07-10 |
4 |
OE |
$1.35 |
$20,250 |
D/D |
15,000 |
132,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-07-10 |
4 |
AS |
$101.06 |
$1,546,300 |
D/D |
(15,000) |
117,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-06-23 |
4 |
AS |
$100.54 |
$504,033 |
D/D |
(5,000) |
112,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-06-23 |
4/A |
OE |
$1.35 |
$6,750 |
D/D |
5,000 |
122,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-06-23 |
4/A |
AS |
$100.54 |
$504,033 |
D/D |
(5,000) |
117,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-06-09 |
4 |
AS |
$84.81 |
$885,491 |
D/D |
(10,000) |
117,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-06-09 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
127,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-04-25 |
4 |
AS |
$80.89 |
$1,227,690 |
D/D |
(15,000) |
117,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-04-25 |
4 |
OE |
$1.35 |
$20,250 |
D/D |
15,000 |
132,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-04-03 |
4 |
AS |
$80.69 |
$409,798 |
D/D |
(5,000) |
117,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-04-03 |
4 |
OE |
$1.35 |
$6,750 |
D/D |
5,000 |
122,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-03-27 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
127,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-03-27 |
4 |
AS |
$75.74 |
$776,746 |
D/D |
(10,000) |
117,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-03-09 |
4 |
OE |
$1.35 |
$28,509 |
D/D |
21,118 |
138,913 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-03-09 |
4 |
AS |
$80.47 |
$1,705,929 |
D/D |
(21,118) |
117,795 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Chief Operating Officer |
• – – |
2017-03-01 |
4 |
AS |
$80.05 |
$2,312,004 |
D/D |
(28,882) |
117,795 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
